Recurrent Pathogenic THRB Variant p. Arg338Trp (c.1012C>T) in a New Family with Pituitary-Selective Resistance to Thyroid Hormone Beta: a case report
AACE Endocrinology and Diabetes · 2026-10
DOI: 10.1016/j.aed.2026.08.025 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-10. Verfasst von Ananda Mohan Chakraborty und 3 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chakraborty, A. M., Kaur, N., Gill, P. K., & Bedi, S. P. S. (2026). Recurrent Pathogenic THRB Variant p. Arg338Trp (c.1012C>T) in a New Family with Pituitary-Selective Resistance to Thyroid Hormone Beta: a case report. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.08.025
Vancouver
Chakraborty AM, Kaur N, Gill PK, Bedi SPS. Recurrent Pathogenic THRB Variant p. Arg338Trp (c.1012C>T) in a New Family with Pituitary-Selective Resistance to Thyroid Hormone Beta: a case report. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.08.025
BibTeX
@article{Chakraborty2026,
author = {Chakraborty, Ananda Mohan and Kaur, Navjot and Gill, Parminder Kaur and Bedi, Surinder Pal Singh},
title = {Recurrent Pathogenic THRB Variant p. Arg338Trp (c.1012C>T) in a New Family with Pituitary-Selective Resistance to Thyroid Hormone Beta: a case report},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.08.025}
}
EUVIMED